Replies to post #75083 on Intellicell Biosciences Inc (fka SVFC)

[Toeinmouth]

IntelliCell BioSciences Files Pre-IND With FDA for Osteoarthritis Lead by Dr. James Andrews
Quote:
Aug 1, 2014 IntelliCell BioSciences, Inc. (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stomovascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has filed its pre-IND with the FDA for a clinical trial in osteoarthritis of the knee under an Investigational New Drug Application (IND). Dr. James Andrews, the legendary orthopedic surgeon will be the principal investigator for the study. inVentiv Health Clinical will serve as the Clinical Research Organization (CRO) for the conduction of this clinical trial in osteoarthritis of the knee in accordance of an Investigational New Drug.

The clinical trial will be conducted at the Pensacola Center of the Andrews' Research and Educational Institute in conjunction with Dr. Adam Anz and Dr. Josh Hackel, prominent physicians at the Institute. To date, IntelliCell's technology for isolating stromal vascular fraction cells from the vasculature of adipose tissue has been used to successfully treat over 60 knees with results lasting as long as 5 years.

http://finance.yahoo.com/news/intellicell-biosciences-files-pre-ind-175253679.html
http://finance.yahoo.com/news/intellicell-biosciences-joins-forces-dr-183000618.html
http://www.fda.gov/Drugs/DevelopmentApprovalprocess/SmallBusinessAssistance/ucm069906.htm
http://finance.yahoo.com/news/inventiv-health-clinical-engaged-intellicell-143800120.html